actinic keratosis

Type: Keyphrase
Name: actinic keratosis
First reported 13 hours ago - Updated 13 hours ago - 2 reports

Tampa Bay Specialist Offers Two-Part Treatment for Pre-Cancerous Actinic Keratosis

Dr. Jeffrey Hunt Provides Non-Surgical Levulan(R) Kerastick(R) and BLU-U(R) Treatments to Eliminate Actinic Keratosis Skin Lesions, Which Can Potentially Develop Into Skin Cancer; This Is Also Called PDT or Photodynamic TherapyTAMPA BAY, FL--(Marketwired ... [Published Scottrade - 13 hours ago]
First reported Sep 04 2014 - Updated Sep 04 2014 - 5 reports

High long-term efficacy of LEO Pharma’s Picato in actinic keratosis confirmed

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato(ingenol mebutate gel) 0.015% is efficacious in treating actinic ... [Published Pharma Letter - Sep 04 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

USAHC Vicenza shines a blue light on skin cancer

Thanks to the generosity of the local Veterans of Foreign Wars organization, U.S. Army Health Center Vicenza now has a machine to treat precancerous and certain superficial skin cancer conditions. Vicenza's VFW Post 8862 purchased a photodynamic therapy ... [Published United States Army - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Forum Post: RE: Cryotherapy for bcc

Hello French Explorer.   I'm sorry that no one has replied to your post yet, so I've popped in from the head / neck group to say that last year I had treatment for a patch of actinic keratosis on the side of my nose ( a pre-cancerous condition ) The patch ... [Published Macmillan Cancer Support - Sep 02 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

BIOFRONTERA : Loss Widens As It Ramps Up For Ameluz Approval In US

LONDON ( Alliance News ) - Biofrontera AG Friday posted a widened pretax loss in the half year to end-June on higher, as it prepares for the US approval of its skin cancer medication Ameluz.Biofrontera posted a pretax loss of EUR5.4 million , widened ... [Published 4 Traders - Aug 29 2014]
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

Harsh UV rays take warmth out of sunny days this rainy season

PUNE: Sun rays beating down the city have been particularly harsh in the last two months. The sunny days in the months of July and August may have given city commuters a little respite from the rain, but the Indian Institute of Tropical Meteorology (IITM) ... [Published Times of India - Aug 23 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 2 reports

Biofrontera confident ahead of FDA meeting on Ameluz

Biofrontera ( LON:B8F ) has been scheduled a meeting with the US Food and Drug Administration ahead of its filing key products Ameluz and BF-RhodoLED for approval.   The pre-NDA meeting, set for 8 October, represents the last opportunity to obtain ... [Published Proactiveinvestors United Kingdom RSS feed - Aug 21 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Biofrontera AG: Belixos® now available through Amazon in Germany and UK

Prof. Hermann Lübbert, Chief Executive Officer of Biofrontera commented: "The UK is the first country outside Germany in which we have made our Belixos® products available. Amazon provides a perfect platform to offer these products to a wide group of ... [Published InfoStor - Aug 18 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Global Non-melanoma Skin Cancer Market 2014-2018

NEW YORKAbout Non-melanoma Skin CancerNon-melanoma skin cancer is one of the most common types of cancer in the world. It develops in the upper layers of the skin, but not in melanocytes. There are two types of non-melanoma skin cancer: BCC, which starts ... [Published Bio-Medicine - Aug 13 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 2 reports

Biofrontera's Ameluz passes first stage approval in Israel

StockMarketWire.com - Biofrontera's Ameluz - a prescription drug for the treatment of mild to moderate Actinic Keratosis (superficial skin cancer) by photodynamic therapy (light therapy) - has passed its first stage approval in Israel. Biofrontera said ... [Published Stock Market Wire - Aug 11 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Biofrontera makes first Ameluz sales in Slovenia

Biofrontera (LON:B8F, ETR:B8F) has recorded the first sales of its prescription drug Ameluz in Slovenia, its maiden revenues from a Central Eastern European country.Ameluz is a topical treatment that tackles actinic keratosis (AK), a very comm...Related ... [Published BioPortfolio - Aug 06 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 2 reports

Kinex announces allowance of IND application for KX2-391 ointment by USFDA

Kinex Pharmaceuticals has announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to be allowed by the US FDA in the ... [Published PBR - News - Jul 25 2014]

Quotes

...professor at the Department of Dermatology, University Hospital Tubingen, Germany, and principal investigator of the FIELD Repeat Study, commented: "AK is a very common precursor to non-melanoma skin cancer, which requires ongoing treatment. The new data from the FIELD Study Repeat validate Picato as a well-tolerated field-directed therapy, suitable for the long-term treatment of actinic keratoses, showing an overall high complete clearance rate after one year."
"The recently published 12 month data from FIELD Study 1 show sustained patient benefits of field treatment with Picato® in combination with cryosurgery. These data are now reinforced with evidence that repeat use of Picato® is efficacious and well tolerated over the same time period. Combined, these studies provide further evidence for the role of field treatment with Picato® in achieving long-term clearance of AK lesions."
"Everyone will benefit from this machine," said VFW Post 8862 trustee Ron Reynolds. "The young folks going through the nasty acne period, older folks that have been exposed to sun for many years as well as our warriors that have been exposed to the hot weather in Afghanistan and Iraq."
...Therefore, a BASF team of sunscreen experts wants to develop a water-in-oil emulsion together with representatives of RDTC. "It is not absorbed as quickly but it offers long lasting protection" says Osterwalder. In the long term, the new sun protection emulsion should replace the existing sunscreen...

More Content

All (32) | News (27) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Tampa Bay Specialist Offers Two-Part Treatment ... [Published Scottrade - 13 hours ago]
Tampa Bay Specialist Offers Two-Part Treatment ... [Published Marketwire - Breaking News Releases - 13 hours ago]
Reset Your Face [Published Texomashomepage.com - Sep 15 2014]
Killers - Areca nut and smokeless tobacco [Published The Nation.lk - Sep 06 2014]
High long-term efficacy of LEO Pharma’s Picato ... [Published Pharma Letter - Sep 04 2014]
New Data Presented at WCCS Confirm High Long-te... [Published FirstWord Pharma - Sep 04 2014]
New Data Presented at WCCS Confirm High Long-te... [Published PRESSEMITTEILUNGEN - Sep 04 2014]
New Data Presented at WCCS Confirm High Long-te... [Published Digital Journal - Sep 04 2014]
New Data Presented at WCCS Confirm High Long-te... [Published Scottrade - Sep 04 2014]
USAHC Vicenza shines a blue light on skin cancer [Published United States Army - Sep 03 2014]
BASF SE : and Regional Dermatology Training Cen... [Published 4 Traders - Sep 03 2014]
Forum Post: RE: Cryotherapy for bcc [Published Macmillan Cancer Support - Sep 02 2014]
BIOFRONTERA : Loss Widens As It Ramps Up For Am... [Published 4 Traders - Aug 29 2014]
Biofrontera's domestic sales remain strong [Published Proactiveinvestors United Kingdom RSS feed - Aug 29 2014]
Harsh UV rays take warmth out of sunny days thi... [Published Times of India - Aug 23 2014]
Biofrontera confident ahead of FDA meeting on A... [Published Proactiveinvestors United Kingdom RSS feed - Aug 21 2014]
Biofrontera AG : FDA pre-New Drug Application m... [Published Investegate - Aug 21 2014]
Biofrontera pre-NDA meeting with FDA scheduled [Published Stock Market Wire - Aug 21 2014]
Biofrontera AG: Belixos® now available through ... [Published InfoStor - Aug 18 2014]
Forum Post: RE: Need help with my mole [Published Macmillan Cancer Support - Aug 16 2014]
What is squamous cell carcinoma? [Published Orthopedics Today - Aug 13 2014]
Global Non-melanoma Skin Cancer Market 2014-2018 [Published Bio-Medicine - Aug 13 2014]
Biofrontera's Ameluz passes first stage approva... [Published Stock Market Wire - Aug 11 2014]
Biofrontera eyes regulatory clearances for skin... [Published Proactive Investors.co.uk - Aug 11 2014]
Biofrontera makes first Ameluz sales in Slovenia [Published BioPortfolio - Aug 06 2014]
Kinex announces allowance of IND application fo... [Published PBR - News - Jul 25 2014]
Kinex Pharmaceuticals Announces Allowance of th... [Published PR Newswire: Health - Jul 24 2014]
Research and Markets: Actinic Keratosis Pipelin... [Published Business Wire Health News - Jul 01 2014]
Skin cancer drug group Biofrontera makes steady... [Published Proactiveinvestors United Kingdom RSS feed - Jun 03 2014]
AIM Admission - First Day of Dealings [Published TrustNet - Jun 03 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Tampa Bay Specialist Offers Two-Part Treatment ... [Published Marketwire - Breaking News Releases - 13 hours ago]
Dr. Jeffrey Hunt Provides Non-Surgical Levulan(R) Kerastick(R) and BLU-U(R) Treatments to Eliminate Actinic Keratosis Skin Lesions, Which Can Potentially Develop Into Skin Cancer; This Is Also Called PDT or Photodynamic Therapy ...
New Data Presented at WCCS Confirm High Long-te... [Published PRESSEMITTEILUNGEN - Sep 04 2014]
Ballerup, Denmark (ots/PRNewswire) – Not for US media The digital press release with multimedia content can be accessed here: http://www.multivu.com/players/uk/7276254-WCCS-Picato-actinickeratosis New data from the international FIELD Study Repeat presented ...
Kinex announces allowance of IND application fo... [Published PBR - News - Jul 25 2014]
Kinex Pharmaceuticals has announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to be allowed by the US FDA in the ...
Kinex Pharmaceuticals Announces Allowance of th... [Published PR Newswire: Health - Jul 24 2014]
BUFFALO, N.Y., July 24, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third ...
Research and Markets: Actinic Keratosis Pipelin... [Published Business Wire Health News - Jul 01 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/smn5g3/actinic_keratosis) has announced the addition of the "Actinic Keratosis Pipeline Highlights - 2014 Update" report to their offering. The latest report Actinic ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.